Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP policies and guidelines news

Show

From To
Indiana HIV outbreak offers lessons about containing local outbreaks and need for harm reduction

An early-2015 outbreak of HIV and hepatitis C virus (HCV) in rural Indiana, USA, linked to injection of prescription opiates, offers a good example of how to

Published
10 August 2015
By
Liz Highleyman
When Might Generic Truvada Be Available for PrEP in the US?

Our best guess is that generic Truvada could be available in December 2017, initially produced by Teva, a major generic producer. Two other generic companies, Lupin Pharmaceuticals and Cipla may follow soon after creating competition that can really bring prices down.

Published
17 March 2015
From
Ethan The Blog
European CDC cautious about PrEP

The European Centre for Disease Prevention and Control (ECDC) has issued a paper saying that it cannot make a clear Europe-wide recommendation on the use of pre-exposure prophylaxis

Published
18 July 2014
By
Gus Cairns
New US guidelines recommend PrEP

The US Centers for Disease Control and Prevention (CDC) today released new guidelines recommending that pre-exposure prophylaxis (PrEP) should be considered for anyone HIV-negative who:Is

Published
14 May 2014
By
Gus Cairns
Who will PrEP be for?

Whether pre-exposure prophylaxis (PrEP) is adopted and is effective as an HIV prevention method depends crucially on people’s subjective assessment of whether they are at risk of HIV,

Published
01 October 2013
By
Gus Cairns
Biomedical HIV prevention – the social complexities of achieving effectiveness

Public health officials, donors, epidemiologists, researchers and clinicians need to factor in the relevance of the social and the cultural if they are to see biomedical HIV

Published
25 July 2013
By
Roger Pebody
PrEP probably cost effective in middle-income countries, but too costly to slash HIV incidence

What is probably the most detailed and realistic modelling study so far done of the impact and cost-effectiveness of pre-exposure prophylaxis (PrEP) finds that it could be very

Published
12 October 2012
By
Gus Cairns
Changing the way HIV prevention is delivered – a roadmap

In the last few years there has been a wealth of dramatic data on the efficacy of new HIV prevention methods, including male circumcision, pre-exposure prophylaxis and

Published
01 August 2012
By
Roger Pebody
NICE says sperm washing is no safer than effective treatment and timed intercourse

Draft UK guidance on fertility treatment says that sperm washing may no longer be necessary for couples where the man has HIV and the woman does not.

Published
22 May 2012
By
Roger Pebody
US regulators vote for approval of PrEP by large majority

The US Food and Drug Administration (FDA) took a decisive step yesterday towards approving the use of the combination pill Truvada (tenofovir/FTC) as a prevention

Published
11 May 2012
By
Gus Cairns

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.